• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原位肝移植后真菌感染的临床谱

Clinical spectrum of fungal infections after orthotopic liver transplantation.

作者信息

Castaldo P, Stratta R J, Wood R P, Markin R S, Patil K D, Shaefer M S, Langnas A N, Reed E C, Li S J, Pillen T J

机构信息

Department of Surgery, University of Nebraska Medical Center, Omaha 68198-3280.

出版信息

Arch Surg. 1991 Feb;126(2):149-56. doi: 10.1001/archsurg.1991.01410260033005.

DOI:10.1001/archsurg.1991.01410260033005
PMID:1992992
Abstract

During a 50-month period, we identified 91 episodes of fungal infection in 72 liver transplant recipients (23.8%). Candida species accounted for 83.5% of cases. Clinical patterns of fungal infections included disseminated infection (19), peritonitis (17), pneumonitis (15), multiple sites of colonization (13), fungemia (11), and other sites (16). The diagnosis of fungal infection was usually made in the first 2 months (84.7% of cases), at a mean time of 16 days after transplantation. Risk factors for fungal infections included retransplantation, Risk score, intraoperative transfusion requirement, urgent status, Roux limb biliary reconstruction (in adults), steroid dose, bacterial infections and antibiotic therapy, and vascular complications. Fungal infections were successfully treated with amphotericin B in 63 cases (74.1%) but were associated with diminished patient survival (50% vs 83.5%). Fungal infection is a frequent source of early morbidity and can be related to well-defined risk factors, suggesting the need for effective prophylaxis.

摘要

在50个月的时间里,我们在72例肝移植受者中发现了91次真菌感染事件(占23.8%)。念珠菌属占病例的83.5%。真菌感染的临床类型包括播散性感染(19例)、腹膜炎(17例)、肺炎(15例)、多部位定植(13例)、真菌血症(11例)和其他部位感染(16例)。真菌感染的诊断通常在头2个月内做出(84.7%的病例),平均在移植后16天。真菌感染的危险因素包括再次移植、风险评分、术中输血需求、紧急状态、Roux袢胆道重建(成人)、类固醇剂量、细菌感染和抗生素治疗以及血管并发症。63例(74.1%)患者使用两性霉素B成功治疗了真菌感染,但这与患者生存率降低相关(50%对83.5%)。真菌感染是早期发病的常见原因,并且可能与明确的危险因素相关,这表明需要进行有效的预防。

相似文献

1
Clinical spectrum of fungal infections after orthotopic liver transplantation.原位肝移植后真菌感染的临床谱
Arch Surg. 1991 Feb;126(2):149-56. doi: 10.1001/archsurg.1991.01410260033005.
2
The risk factors of fungal infection in living-donor liver transplantations.活体肝移植中真菌感染的危险因素。
J Hepatobiliary Pancreat Sci. 2012 Jul;19(4):382-8. doi: 10.1007/s00534-011-0423-4.
3
Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.一项前瞻性干预性研究,旨在评估脂质体两性霉素B对高危肝移植受者真菌感染的预防效果及安全性。
Transplant Proc. 2005 Nov;37(9):3965-7. doi: 10.1016/j.transproceed.2005.10.043.
4
Prospective screening in liver transplant recipients by panfungal PCR-ELISA for early diagnosis of invasive fungal infections.通过泛真菌聚合酶链反应-酶联免疫吸附测定法对肝移植受者进行前瞻性筛查,以早期诊断侵袭性真菌感染。
Liver Transpl. 2007 Jul;13(7):1011-6. doi: 10.1002/lt.21175.
5
Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.氟康唑与小剂量两性霉素B预防造血干细胞移植患者真菌感染的随机试验
Am J Hematol. 2002 Dec;71(4):260-7. doi: 10.1002/ajh.10234.
6
Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.脂质体两性霉素B(安必素)预防肝移植受者真菌感染:一项随机、安慰剂对照试验的长期结果
Transplant Proc. 1995 Feb;27(1):1195-8.
7
Trends in invasive fungal infections in liver transplant recipients: correlation with evolution in transplantation practices.
Transplantation. 2002 Jan 15;73(1):63-7. doi: 10.1097/00007890-200201150-00011.
8
Retrospective analysis of yeast colonization and infections in paediatric bone marrow transplant recipients.儿科骨髓移植受者酵母定植与感染的回顾性分析
Mycoses. 1997 Jan-Feb;40(1-2):47-54. doi: 10.1111/j.1439-0507.1997.tb00170.x.
9
Candida infection in pediatric liver transplant recipients.儿童肝移植受者的念珠菌感染
Liver Transpl Surg. 1999 Jan;5(1):16-24. doi: 10.1002/lt.500050105.
10
Fungal infections in solid organ recipients.实体器官移植受者中的真菌感染
Exp Clin Transplant. 2005 Dec;3(2):385-9.

引用本文的文献

1
Liver Transplantation Without Systemic Antifungal Prophylaxis-An Exceptional Perspective from a Single Center Experience.不进行全身抗真菌预防的肝移植——来自单一中心经验的独特视角。
J Clin Med. 2025 Jul 1;14(13):4663. doi: 10.3390/jcm14134663.
2
In-hospital mortality of liver transplantation and risk factors: a single-center experience.肝移植的院内死亡率及危险因素:单中心经验
Ann Transl Med. 2021 Mar;9(5):369. doi: 10.21037/atm-20-5618.
3
Catastrophic Brain Aspergillosis after Liver Transplantation.肝移植术后的灾难性脑曲霉病
Case Rep Transplant. 2021 Feb 13;2021:8626057. doi: 10.1155/2021/8626057. eCollection 2021.
4
Regulated Cell Death as a Therapeutic Target for Novel Antifungal Peptides and Biologics.调控细胞死亡作为新型抗真菌肽和生物制剂的治疗靶点。
Oxid Med Cell Longev. 2018 Apr 26;2018:5473817. doi: 10.1155/2018/5473817. eCollection 2018.
5
Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.已故供体和活体供体肝移植受者的围手术期细菌感染
J Clin Exp Hepatol. 2012 Mar;2(1):35-41. doi: 10.1016/S0973-6883(12)60081-4. Epub 2012 Apr 12.
6
Nosocomial infections within the first month of solid organ transplantation.实体器官移植后第一个月内的医院感染
Transpl Infect Dis. 2014 Apr;16(2):171-87. doi: 10.1111/tid.12203. Epub 2014 Mar 24.
7
Aspergillosis of biliary tract after liver transplantation: a case report.肝移植后胆道曲霉病:病例报告。
Mycopathologia. 2010 Aug;170(2):117-21. doi: 10.1007/s11046-010-9300-y. Epub 2010 Mar 24.
8
Noninvasive ventilation for patients near the end of life: what do we know and what do we need to know?终末期患者的无创通气:我们知道什么以及我们需要知道什么?
Crit Care Med. 2008 Mar;36(3):1003-4. doi: 10.1097/CCM.0B013E318165FD78.
9
Aspergillus infections in transplant recipients.移植受者中的曲霉感染。
Clin Microbiol Rev. 2005 Jan;18(1):44-69. doi: 10.1128/CMR.18.1.44-69.2005.
10
Antifungal agents for preventing fungal infections in solid organ transplant recipients.用于预防实体器官移植受者真菌感染的抗真菌药物。
Cochrane Database Syst Rev. 2004(3):CD004291. doi: 10.1002/14651858.CD004291.pub2.